Navigation Links
Uroplasty Reports Financial Results for the Second Quarter FY2011
Date:10/27/2010

ubsidiaries in The Netherlands and the United Kingdom, is a medical device company that develops, manufactures and markets innovative proprietary products for the treatment of voiding dysfunctions. Our focus is the continued commercialization of our Urgent PC system, which we believe is the only FDA-approved minimally invasive nerve stimulation device designed for office-based treatment of urinary urgency, urinary frequency and urge incontinence – symptoms often associated with overactive bladder.

We also offer Macroplastique Implants, an injectable urethral bulking agent for the treatment of adult female stress urinary incontinence primarily due to intrinsic sphincter deficiency. For more information on the company and its products, please visit Uroplasty, Inc. at www.uroplasty.com.

Forward-Looking InformationThis press release contains forward-looking statements that reflect our best estimates regarding future events and financial performance. These forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from our anticipated results. We discuss in detail the factors that may affect the achievement of our forward-looking statements in our Annual Report on Form 10-K filed with the SEC. In particular, we cannot be certain that the CPT Code for the PTNS procedures in which Urgent PC is used will be timely published, that the rate of reimbursement for such procedures will be adequate to justify the cost of our product, that the amount and rate at which we apply funds to expand our sales force will be justified by increased sales, that larger competitors will not introduce products or pharmaceuticals that target the portion of the market for which Urgent PC is designed, that sales of our Macroplastique product will continue to increase, that percutaneous nerve stimulation will ever be an accepted, and FDA-cleared, procedure for the treatment of fe
'/>"/>

SOURCE Uroplasty, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Uroplasty to Issue Second Quarter 2011 Results on October 27, 2010
2. Uroplasty to Present at The 5th Annual JMP Securities Healthcare Conference
3. Coverage Initiated by Two Regional Medicare Carriers for Posterior Tibial Nerve Stimulation (PTNS) Delivered Via Uroplastys Urgent® PC Neuromodulation System
4. Uroplasty to Present at Global Hunter Securities Inaugural Healthcare Conference
5. Uroplasty Reports Results for Second Quarter FY2010
6. Uroplasty to Issue Second Fiscal Quarter Results on November 2, 2009
7. Uroplasty Highlights Results From Clinical Study on Macroplastique(R) for the Treatment of Stress Urinary Incontinence
8. Uroplasty Enrolls First Patients in Urgent(R) PC Clinical Trial
9. Uroplasty Highlights Clinical Results From a Study of the Urgent(R) PC Neuromodulation System
10. Endologix Reports 30% Third Quarter 2010 Revenue Growth
11. Pharmos Corporation Reports 2010 Third Quarter Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... May 23, 2013  BioElectronics Corporation (OTC Pink: BIEL), ... comments on the FDA panel meeting for non-thermal shortwave ... – Pulsed Shortwave Therapy Meeting was held on May ... USA.  The focus of the meeting was very narrow, ... focus solely on the application of non-thermal shortwave diathermy ...
(Date:5/23/2013)... May 23, 2013 Halozyme Therapeutics, Inc. ... appointment of David A. Ramsay ... most recently Vice President, Corporate Development at Halozyme. ... "With his established financial management experience and ... working in our commercial group for the last ...
(Date:5/23/2013)... , May 23, 2013 Isis Pharmaceuticals, Inc. ... today announced that management will present a company overview at ... Conference on Thursday, May 30, 2013 at 8:40 a.m. ET ... live audio webcast of the presentation will be available on ... www.isispharm.com .  A replay will be available on the ...
Breaking Medicine Technology:BioElectronics and Pulsed Shortwave Therapy Make Progress 2Halozyme Therapeutics Names David A. Ramsay Chief Financial Officer 2Isis Pharmaceuticals to Present at the Deutsche Bank 38th Annual dbAccess Health Care Conference 2
... Pfizer Inc. (NYSE: PFE ) today announced, at the ... the chronic low back pain and painful diabetic peripheral neuropathy studies in ... continues in some areas of high unmet medical need, including cancer pain. ... (Logo:   http://photos.prnewswire.com/prnh/20100416/PFIZERLOGO ...
... Heslin , MD of Bridge Street Medical Group will discuss use of health IT ... 20 , , , ... July 19 If a small general medical practice in ... health care for its patients, so can practices across the nation. That is the ...
Cached Medicine Technology:Pfizer Suspends Chronic Pain Studies in Tanezumab Clinical Trial Program; Some Studies Continue in Areas of Unmet Medical Need 2Hudson Valley Physician Testifies Before House Health Subcommittee Tuesday About Incentives for Adoption of Health Information Technology 2Hudson Valley Physician Testifies Before House Health Subcommittee Tuesday About Incentives for Adoption of Health Information Technology 3
(Date:5/23/2013)... it when a woman harried by hot flashes says ... study published online in Menopause , the journal ... with objective tests that what these women say about ... studies showed that hot flashes were related to memory ... though there was a relationship between hot flashes and ...
(Date:5/23/2013)... Susquehanna Health is now a ... training course for adolescents age 11 and up. ... Dr. Patricia Keener after a colleague’s toddler choked to ... who didn’t know how to provide first aid. Safe ... medical basis that aims to reduce the number of ...
(Date:5/23/2013)... An anti-cancer drug about to be tested in a ... a possible treatment for Alzheimer,s disease has failed to ... plague Alzheimer,s patients, according to results of a study ... a professor of neuroscience affiliated with the Evelyn F. ... of Florida, emphasized the importance of verifying promising research ...
(Date:5/23/2013)... The Rottenstein Law Group LLP, a New ... Tylenol Lawsuit Information Center at http://www.rotlaw.com/tylenol , dedicated ... who are considering filing lawsuits. , The painkiller ... liver damage, according to a 2009 report from the ... communication,” the FDA warned consumers against using more than ...
(Date:5/23/2013)... Former United States Vice President Dick Cheney served as ... Luncheon. , In front of 1,500 guests yesterday ... saying, "I am delighted to be here to have ... the Year Award. I think it's a tremendous recognition; ... a company like this because there are obviously a ...
Breaking Medicine News(10 mins):Health News:Susquehanna Health Offers Safe Sitter Course for Tweens and Teens 2Health News:Susquehanna Health Offers Safe Sitter Course for Tweens and Teens 3Health News:Anti-cancer drug viewed as possible Alzheimer's treatment doesn't work in UF study 2Health News:Anti-cancer drug viewed as possible Alzheimer's treatment doesn't work in UF study 3Health News:Rottenstein Law Group LLP Now Accepting Tylenol Cases, Announces New Tylenol Lawsuit Information Center 2Health News:Acadian Ambulance Honors Paramedic of the Year at Annual Luncheon 2
... this summer and a friend dares you to eat a raw ... hospital with a severe parasitic infection. Physicians at Washington University ... infection in six people who had consumed raw crayfish from streams ... years, but three have been diagnosed since last September; the latest ...
... ... statistics on the top-performing companies for the past six months, Jusuru International is the fastest ... ... has just released its statistics on the top-performing companies for the past six months, Jusuru ...
... Massachusetts Medical School report in the journal Nature Medicine ... malignant glioma, a pathway essential to the cancer,s ability ... that would stop the cancer,s ability to thrive. ... RNA interference screen reveals an essential CREB3L2-ATF5-MCL1 survival pathway ...
... infection improves patient outcomes, researchers say , TUESDAY, May ... ailment chronic obstructive pulmonary disease (COPD) do better when ... , COPD patients who were given antibiotics early in ... ventilation and less likely to have to be readmitted ...
... ... Version of Pearson Author Elana Zucker’s Best-selling Textbook, Being a Home Health Aide , ... Indianapolis, IN (PRWEB) May 25, 2010 ... decade, the Indiana Home and Hospice Care (IHHC) Foundation needed to quickly overhaul its outdated ...
... suggest that bacteria residing in the the human intestinal ... developing colon cancer. Scientists from the University of Florida ... of the American Society for Microbiology in San Diego, ... are more frequently detected in subjects with polyps, early ...
Cached Medicine News:Health News:Dangerous lung worms found in people who eat raw crayfish 2Health News:Dangerous lung worms found in people who eat raw crayfish 3Health News:Dangerous lung worms found in people who eat raw crayfish 4Health News:,Jusuru Tops New Company Launch Rankings, 2Health News:Novel RNA interference screening technique identifies possible path for malignant glioma treatment 2Health News:Quick Use of Antibiotics Best for COPD Flare-Ups 2Health News:Quick Use of Antibiotics Best for COPD Flare-Ups 3Health News:Indiana Home and Hospice Care Foundation Selects Pearson to Bolster Workforce Training Initiatives 2Health News:Indiana Home and Hospice Care Foundation Selects Pearson to Bolster Workforce Training Initiatives 3
... The FLU OIA test is a ... diagnosis of Influenza A and B with ... answer in just over 15 minutes. Assay ... specimen flexibility, and performance equivalent to 14-day ...
The CdTOX A OIA gets the results you need without specimen extraction or instrumentation. Results are available in minutes vs hours or days for EIA or other methods. The combination of performance, ...
... provides superior performance for the diagnosis ... that provides an answer in 6 ... will convince you of this tests ... deliver improved patient care with a ...
... for Botox therapy and nerve block ... injectable needle has a precisely machined ... with an attached 61-cm (24-in) lead ... insertion. Single patient use only. A ...
Medicine Products: